ebastine
UkraineDrugs containing this active substance
-
The drug is used for the symptomatic treatment of allergic rhinitis (seasonal or perennial), chronic idiopathic urticaria, and allergic dermatitis.
Form: tablets, dispersible in the oral cavity
Active substance Dosage ebastine 10 mg ATC: R06AX22
Manufacturer: Micro Labs Limited
-
The drug is used for the symptomatic treatment of allergic rhinitis (seasonal or perennial), chronic idiopathic urticaria, and allergic dermatitis.
Form: tablets, dispersible in the oral cavity
Active substance Dosage ebastine 10 mg ATC: R06AX22
-
The drug is used for the symptomatic treatment of allergic rhinitis (seasonal or perennial), chronic idiopathic urticaria, and allergic dermatitis.
Form: tablets, dispersible in the oral cavity
Active substance Dosage ebastine 20 mg ATC: R06AX22
-
The drug is used for the symptomatic treatment of allergic rhinitis (seasonal and perennial), chronic idiopathic urticaria, and allergic dermatitis.
Form: tablets, film-coated
Active substance Dosage ebastine 10 mg ATC: R06AX22
Manufacturer: Industrias Farmaceuticas Almirall SA
-
The drug is used for the symptomatic treatment of allergic rhinitis (seasonal and perennial), as well as chronic idiopathic urticaria and allergic dermatitis.
Form: tablets, film-coated
Active substance Dosage ebastine 20 mg ATC: R06AX22
Manufacturer: Industrias Farmaceuticas Almirall SA
-
The drug is used for the symptomatic treatment of allergic rhinitis (seasonal and perennial), chronic idiopathic urticaria, and allergic dermatitis.
Form: tablets, film-coated
Active substance Dosage ebastine 10 mg ATC: R06AX22
Manufacturer: Generis Pharmaceutica, S.A.
-
The drug is used for the symptomatic treatment of allergic rhinitis (seasonal and perennial), as well as chronic idiopathic urticaria and allergic dermatitis.
Form: tablets, film-coated
Active substance Dosage ebastine 20 mg ATC: R06AX22
Manufacturer: Generis Pharmaceutica, S.A.